SuRo Capital Corp. (SSSS) Earnings Call Transcript & Summary

March 11, 2025

NASDAQ US Financials Capital Markets earnings 37 min

Earnings Call Speaker Segments

Jackson Stone

executive
#1

Thanks for being with us on the call today. With me are SuRo Capital's Chairman and Chief Executive Officer, Mark Klein, along with our Chief Financial Officer, Allison Green. A slide deck that matches management's prepared remarks for today is posted on our site, www.surocap.com, beneath Investor Relations, Events and Presentations. This call is being recorded and streamed live at www.surocap.com. Details on how to access a replay can be found in the press release we issued today. This call belongs to SuRo Capital, and reproducing it without authorization in any form is strictly forbidden. I'd also like to direct your attention to the customary disclosures about forward-looking information contained in today's earnings press release. Today's conference call and webcast may contain forward-looking statements about upcoming events or how we might perform or fare financially down the road. These statements aren't promises regarding what will happen with our performance, financial condition, or results in the future, and they come with various risks, estimates, and uncertainties. One such risk is the effect of market volatility, which could hurt our operations, the companies in our portfolio, our sector, and the worldwide economy. As a result, actual outcomes might diverge significantly from the plans, intentions, and expectations expressed or implied by those forward-looking statements. Several elements might lead real outcomes to diverge substantially from what those forward-looking statements suggest, among them the ones outlined occasionally within the company's SEC submissions, though that list isn't exhaustive. Unless the law demands it, management won't commit to revising any such forward-looking statements. Copies of SuRo Capital's most recent SEC filings can be found by heading to our site, www.surocap.com, or by checking sec.gov. At this point, I'll hand things over to Mark Klein.

Mark David Klein

executive
#2

Thanks, Jackson. Good afternoon, everyone. I want to express my appreciation to all of you for being on the call today, and to our investors for the backing you continue to give us. It's a pleasure to report SuRo Capital's results for the fourth quarter and for fiscal year 2024. We're particularly glad to have so many first-time participants with us; given that, we'll begin with a brief background on SuRo before explaining why we think our portfolio has reached a significant inflection point. Our firm was launched 14 years ago, built on the belief that businesses would remain private for longer, with the goal of giving investors exposure to market-leading private companies ahead of their public debuts. That belief has been borne out. At the time SuRo began, the number of unicorns stood below 100. Now, we count approximately 1,500 unicorns, 50 decacorns, and a small number of hectocorns. During those years, we've held a variety of standout technology businesses, such as Facebook, Twitter, Snap, Spotify, Lyft, Dropbox, Palantir and Coursera, among others. We've been through numerous strong market cycles, among them mid-2020 through early '22, when we turned over $250 million-plus of our portfolio assets and declared and paid distributions totaling roughly $9 per share. Like every BDC, we must distribute effectively all of our net realized gains. In line with how we've operated previously, we'll be open and communicative regarding our dividend strategy. Right now, we think we're witnessing yet another one of those extremely attractive moments in the market. Among the next wave of anticipated IPOs in our portfolio are CoreWeave, Canva, WHOOP, Liquid Death, Lime, VAST Data and, at some point in time, OpenAI. This pipeline of pre-IPO businesses is as big as any we can remember in the fund's history. In our view, the IPO window is reopening, and this is a remarkably exciting moment for our portfolio as we move toward potential monetizations. We're already witnessing promising IPO activity building within our portfolio. On March 3, CoreWeave submitted its S-1 ahead of what has been widely reported as one of the year's most highly anticipated IPOs. Per a Bloomberg report, CoreWeave's IPO is expected to target a valuation above $35 billion and is looking to raise approximately $4 billion. CoreWeave's prospectus shows the company brought in $1.9 billion in 2024 revenue, over 8x greater than in 2023. Based on a report from the information, CoreWeave anticipates that tremendous growth will continue, projecting $8 billion in 2025 revenue. After CoreWeave's IPO filing, the company announced it had signed a significant contract with OpenAI. Per a company press release, CoreWeave signed a 5-year contract with OpenAI worth up to $11.9 billion, a deal that would also give OpenAI a $350 million equity stake in CoreWeave. In addition, the company announced it reached an agreement to acquire Weights and Biases, a leading AI developer platform. This deal broadens CoreWeave's cloud offering by delivering a full, start-to-finish experience to clients, and it boosts what the world's top AI labs and enterprises can do when creating, refining, and rolling out AI applications. A report from The Information indicates CoreWeave is buying Weights and Biases at a valuation of $1.7 billion. During Q4, as we said before, we put in an extra $5 million as a follow-on investment into CoreWeave's Series A shares through a secondary transaction. That move lifted our total cost basis in CoreWeave to $25 million, which makes CoreWeave the biggest single investment ever made by our fund. Given its best-in-class cloud infrastructure, we think CoreWeave will keep growing exponentially and take advantage of faster AI adoption. We're happy to witness the company's enormous success so far and we're eager for its upcoming IPO. This is precisely the kind of pre-IPO exposure we aim to give our shareholders. Now I'll turn to our other AI infrastructure investments, OpenAI and VAST Data, beginning with OpenAI. During Q3, as previously announced, we invested $17.5 million into OpenAI via the Class A interest of ARK Type One Deep Ventures Fund. Per a Wall Street Journal report from last month, along with numerous other news outlets, OpenAI is negotiating to raise $40 billion at a $300 billion valuation. To frame this relative to our portfolio, should a financing close at that valuation, we expect our OpenAI investment would be worth roughly twice as much. Beyond this financing, it was announced that OpenAI is a lead partner in The Stargate Project. Per the company's website, The Stargate Project plans to invest $500 billion across the next 4 years, constructing new AI infrastructure for OpenAI within the United States. Now for the business itself since our last update. OpenAI has achieved major progress in its consumer and enterprise offerings alike. The company recently rolled out ChatGPT-4.5, an advanced multimodal model that improves speed, accuracy and reasoning capabilities across text, image and audio inputs. OpenAI's growth has been extraordinary. Per a report from The Information, OpenAI expects to more than triple this revenue to more than triple this year from $3.7 million to more than $12.5 million and expects 2026 revenue to reach $28 billion. Per a Reuters report, last month, Open AI had more than 400 million active users. By comparison, per a report from The Information in January 2024, OpenAI had approximately 110 million active users. Per a Reuters report on the enterprise side, OpenAI has more than 2 million paying business customers, more than double the number of business customers it had in September. During the quarter, as previously announced, we invested $12 million into VAST Data through the membership interest of IH10 LLC, an SPV whose sole portfolio asset is an interest in VAST Data's Series B preferred shares. VAST Data is a data management solution for leading AI companies. The reason VAST came into existence is that older approaches to managing data simply couldn't meet the needs of customers who are developing sophisticated AI applications. For a span of several decades, software for enterprise data was designed with tiers as its core idea. Tiered storage refers to segmenting information according to how critical it is for everyday operations. AI applications, though, require simultaneous access to every piece of data, which makes the tiered storage approach more and more outdated. VAST eliminates the tiered storage model entirely by providing all-flash storage. With all-flash storage, everything within a pipeline can be reached immediately, rather than only the data sitting in one particular tier. That matters a great deal for businesses that train AI models to generate outputs. Since the last time we provided an update, VAST has kept growing its footprint in the AI infrastructure arena via important partnerships and fresh product breakthroughs. Not long ago, the NHL chose VAST Data as its partner for data infrastructure to back NHL Edge, the league's platform for advanced analytics. VAST Data will be used by the NHL to drive real-time tracking of both players and the puck, creating fresh insights for teams, broadcasters and fans. In addition, VAST Data recently introduced InsightEngine, an analytics platform powered by next-generation AI that was built together with NVIDIA. InsightEngine lets organizations examine massive data sets immediately, harnessing accelerated computing power to enable decisions made in real time. VAST Data has swiftly established itself as a leading provider of AI infrastructure.

Mark David Klein

executive
#3

A press release from the company late in 2023 stated that VAST Data's ARR had surpassed $200 million. On top of that, for 3 years running, the business had been generating positive cash flow. PitchBook reports that VAST Data has brought in nearly $400 million of equity financing, with participation from investors including NEA, General Atlantic, TPG, and others. Our view is that VAST Data is set up for growth as a top-tier data management provider serving the AI world. Before I go into further updates across our portfolio, I want to discuss our fourth quarter results. We closed out the quarter with net asset value of $157.6 million, equal to $6.68 per share. Kindly refer to Slide 10. As of December 31, SuRo Capital's 5 largest positions were CoreWeave — this encompasses our $15 million investment in CW Opportunity 2 LP plus our combined $10 million of follow-on secondary investments in CoreWeave — OpenAI by way of our investment in ARK Type One Deep Ventures Fund, Learneo, Blink Health, and WHOOP. At fair value, these holdings made up roughly 44% of the investment portfolio. Furthermore, as of December 31, our 10 largest positions represented about 74% of the investment portfolio. At year-end, our liquid assets came to roughly $23.6 million, which is 10% of our gross assets. Moving along to the rest of our portfolio. During December, ServiceTitan set its IPO price at $71 per share, exceeding the expected range and bringing in about $625 million. On its first trading day, it finished at $101 per share, a 42% gain. As of today, ServiceTitan stock ended above $85 per share, comfortably higher than our cost basis. We're happy with ServiceTitan's robust public market debut, and we anticipate it will be the first among multiple IPOs from our current portfolio. As usual, our ServiceTitan public shares carry a 180-day lockup period starting from the IPO date. Now on to Canva. As we've covered before, Canva is an online design productivity software and collaboration platform whose mission is to empower everyone worldwide to design. Per the company's website, by December, Canva's monthly users exceeded 220 million across more than 190 different countries, an increase from 200 million monthly users in October. Also per that source, Canva reached the milestone of 30 billion designs made by the Canva community — that works out to over 38.5 million designs being created each day now; on the enterprise front, the company said that over 95% of the Fortune 500 uses Canva to create, collaborate and communicate — and communicate. A CNBC report indicates Canva now produces roughly $2.5 billion in annualized revenue. As discussed earlier, the company said it had finished multiple secondary transactions at a $32 billion valuation, higher than the $26 billion valuation from its larger company tender in April. We invested $10 million into Canva on terms comparable to the reported April company tender. Switching to WHOOP. After year-end, we completed a $1 billion follow-on investment in WHOOP through a safe note, which lifts our total cost basis to $11 million. Back in the second quarter of 2022, we put our first $10 million into WHOOP through a secondary transaction. From the time of that first check onward, WHOOP has cemented its standing as a top player in wearables for fitness and performance tracking. During the past year, the company pushed into a number of important overseas markets, among them the Middle East, where consumer uptake has been robust and brand awareness keeps climbing. WHOOP has likewise kept setting itself apart as the wearable of choice for elite athletes and high-performance individuals. As proof of its standing at the very top of sports, Cristiano Ronaldo signed on as a global brand partner, boosting WHOOP's profile in elite performance training. On top of that, Patrick Mahomes sported WHOOP at the Super Bowl, putting the device on display for tracking and fine-tuning athletic performance in real time on sports' biggest stage. Now I'd like to give you an update on Liquid Death, one of our portfolio companies. A month ago, Liquid Death ran its first national Super Bowl commercial, a major milestone for the company's marketing strategy; beyond that big marketing push since we invested, Liquid Death has broadened its lineup by rolling out soda-inspired sparkling waters. With the new flavors — Killer Cola, Doctor Death and Rootbeer Wrath — consumers get a distinctive spin on soda tastes, which fits the media brand's edgy approach. Adding soda-flavored sparkling water builds on an already expanding portfolio of teas, sparkling waters and still waters. What these moves show is Liquid Death's dedication to innovative market and product diversification, strengthening its place as a disruptive force in beverages. We're thrilled by Liquid Death's trajectory and stay confident in its potential to disrupt the beverage market even further. The company's dedication to marketing and product innovation shows its capacity to stand out in a competitive market, and we're eager to back its continued success. Kindly turn to Slide 15. Now to our SPAC investments; we're pleased to report that we fully exited our position in Oklo during the fourth quarter, earning a significant return of more than 20x the capital we initially invested in AltC Sponsor LLC, the sponsor of AltC Acquisition Corp. On top of that, we sold all of our PublicSquare common shares at a significant profit. After year-end, Colombier Acquisition II announced it had entered into a definitive business combination agreement. That transaction should close this summer. All of these examples testify to the success of the SPAC sponsor strategy we put in place several years ago. Allison will share more detail on our public positions and investment monetizations in her remarks. Before handing the call to Allison, I want to reiterate how thrilled we are about where our portfolio stands. Across AI infrastructure and applications and consumer goods and services, our portfolio is packed with market-leading companies on the verge of IPOs. Within AI infrastructure, CoreWeave, OpenAI and VAST Data represent 1/4 of gross assets and 37% of our net assets; in 2024 alone, we invested nearly $55 million in AI infrastructure. When it comes to businesses tied to AI, we hold Canva, ServiceTitan, WHOOP, Blink Health, and Locus Robotics, which together account for a further 29% of gross assets. On the consumer side, Liquid Death and Lime stand out as 2 fast-moving category leaders whose operations have grown large enough to support IPOs. Taken as a whole, these positions let our investors own stakes in several of the private market's most eagerly awaited pre-IPO companies. I appreciate everyone listening. With that, I'll pass things to our Chief Financial Officer, Allison Green.

Allison Green

executive
#4

Thanks, Mark. After Mark's update, I'd like to walk through a more thorough look at our Q4 and the financial results through December 31, plus a quick summary of what's happened since the year ended. That covers what we've been investing in, where things stand with our 6% notes maturing in 2026, buybacks of shares, the 6.5% convertible notes maturing in 2029, and our liquidity right now. As Mark noted, in Q4 we finished a $12 million investment into the membership interest of IH10, LLC. The only portfolio asset IH10, LLC holds is an interest in VAST Data's Series B preferred shares, held through an SPV. On top of that, in Q4 we put $5 million more into CoreWeave's Series A preferred shares via a secondary transaction. Combined with the $15 million we invested in the Class A interest of CW Opportunity 2 LP — an SPV whose Class A interest is invested solely in CoreWeave, Inc.'s Series C preferred shares — and the $5 million additional investment into CoreWeave's common shares through a secondary transaction, both of which happened earlier this year, our aggregate exposure to CoreWeave on a cost basis is now $25 million. After the year closed, we made a $1 million follow-on investment in WHOOP through a safe note, which brings our total investment in WHOOP so far to roughly $11 million, along with an extra $300,000 follow-on investment in Orchard Series 1 senior preferred shares and a Safe note, lifting our aggregate investment in Orchard to date to about $12.8 million. In November, we exited Oklo once our lockup restrictions expired; we had received Oklo public common stock after its merger with AltC Acquisition Corp closed successfully, and we'd invested about $250,000 in that SPAC sponsor. The sale generated proceeds of roughly $5.1 million, for a net realized gain of about $4.8 million on the investment. Through Q4, we kept selling off our stake in PublicSquare's public common shares, and as of December 3 we've fully exited. We got PublicSquare public common stock and public warrants after its merger with the First Colombier SPAC closed successfully, and we'd invested about $2.6 million in that SPAC sponsor. In Q4, we sold the last 1,616,187 PublicSquare common shares for approximately <<inaudible>> net proceeds, producing a realized gain of about $4 million. Also in Q4, we kept monetizing our PublicSquare public warrants, selling 500,000 of them for roughly $539,000 in net proceeds, which gave us a realized gain of about $324,000. So far, we've sold 1,976,032 public common shares and 903,963 public warrants of PublicSquare, generating roughly $7.3 million in net proceeds and a realized gain to date of about $5.3 million. To wrap up the quarter, we divested 125,000 publicly traded common shares of Forge. That brought us net proceeds of roughly $130,000 along with a realized gain of about $14,000. In addition, we obtained a distribution of approximately $143,000 tied to our stake in True Global Ventures 4 Plus. If you'd kindly move to Slide 16. Our investment portfolio, broken down across 7 general investment themes, had its largest allocation at year-end in artificial intelligence, infrastructure and applications — roughly 28% of the portfolio at fair value. Software-as-a-service and applications, together with consumer goods and services, came in as the following biggest categories, at about 24% and 14% of our portfolio, respectively. Education technology companies made up approximately 13% of what we hold, while the logistics and supply chain category represented around 11% of our portfolio's fair value. Financial technology and services came to 8% of fair value, and SuRo's sports stood at 2% as of December 31. Kindly turn to Slide 17. I want to walk through greater detail regarding the note repurchase program covering the 6% notes due 2026, as well as the issuances of our 6.5% convertible notes due 2029. SuRo Capital's Board gave approval on August 6, 2024, to a discretionary note repurchase program. This lets the company buy back as much as $35 million of our 6% notes due 2026, excluding any applicable fees, via open market purchases — block purchases included — in a manner consistent with the Investment Company Act of 1940 as amended and the Securities Exchange Act of 1934 as amended. Across the quarter that closed December 31, 2024, we bought back another 203,168 of the 6% notes due 2026 through the note repurchase program. By December 31, our repurchases under the note repurchase program totaled 1,213,304 of the 6% notes due 2026. After year-end and up through today, we bought back a further 199,990 of the 6% notes due 2026 through the note repurchase program. So far, $1,616,462, or approximately $35.3 million in aggregate principal dollar amount of the 6% notes, has been repurchased for about $35 million, which means the authorized available funds have been fully used. Now let's shift to the 6.5% convertible note issuance; on August 6, SuRo Capital signed a note purchase agreement between the company and a private purchaser, under which we can issue up to a maximum of $75 million in aggregate principal amount of 6.5% convertible notes due 2029. Under that note purchase agreement, on August 14, we issued and sold — and the Purchaser bought — $25 million in aggregate principal amount of the convertible notes, which are also called the initial notes. According to the note purchase agreement, if the company and the purchaser both agree, we have the option to issue more convertible notes carrying identical terms to the additional notes, for sale and later offerings to the purchaser — these we call additional notes. Alternatively, we could issue more notes with revised pricing terms, which we call new notes. Combined, the additional notes and new notes can total no more than $50 million, spread across one or more private offerings. Interest on these convertible notes gets paid quarterly in arrears, specifically on March 30, June 30, September 30, and December 30, at an annual rate of 6.5%. Maturity for the convertible notes falls on August 14, 2029, and we may redeem them in whole or in part at any time or from time to time at our option on or after August 6, 2027, provided certain conditions are met. At the purchaser's sole discretion, the convertible notes can be converted into shares of our common stock, starting with an initial conversion rate of 129.0323 shares of common stock for each $1,000 in principal amount of convertible notes, subject to adjustments and limitations outlined in the note purchase agreement. We intend to use the net proceeds from the convertible notes offering to repay outstanding indebtedness, make investments consistent with our investment objective and investment strategy, and for other general corporate purposes. The note purchase agreement contains customary representations, warranties, and covenants from the company. Then on October 9, 2024, under the note purchase agreement, we issued and sold — and the Purchaser bought — $5 million in aggregate principal amount of additional notes.

Allison Green

executive
#5

After the year ended, under the note purchase agreement dated January 16, we issued and sold an extra $5 million in aggregate principal amount of additional notes to the Purchaser. Those $10 million of additional notes in total are handled as one series together with the initial notes, carrying identical terms. The additional notes are fungible and rank on par with the initial notes. When the most recent additional notes were issued on January 16, 2025, the aggregate principal amount outstanding of our 6.5% convertible notes due 2029 reached $35 million. Kindly go to Slide 18; we closed the fourth quarter and fiscal year 2024 with an NAV per share of $6.68, matching our financial reporting. The drop in NAV per share from $6.73 at the close of Q3 was mainly caused by a $0.22 per share decline from the net change in unrealized depreciation of our investments, a $0.16 per share decline attributable to net investment loss, and a $0.06 per share decline stemming from the impact of stock-based compensation in the quarter. That drop in NAV per share was offset by a $0.39 per share gain coming from net realized gain on our portfolio investments in the quarter. On liquidity at year-end, we finished the year holding roughly $23.6 million of liquid assets, which included about $20 million in cash and about $3.6 million in unrestricted public securities. The $14 million of public securities subject to lockup or other sales restrictions at year-end are excluded from that balance. I want to wrap up with a few notes about our share repurchase program. As Mark said earlier, SuRo Capital is dedicated to initiatives that boost shareholder value. So, as previously announced, on October 29 our Board of Directors approved a $4.3 million expansion of the share repurchase program, bringing it to $64.3 million, along with an extension of the program through October 31, 2025. Since the share repurchase program began in August 2017, we have bought back more than 6 million shares of our common stock in total, deploying roughly $39.3 million of the $64.3 million authorized by the Board. About $25 million is still authorized under the share repurchase program, which is now scheduled to expire in October 2025. As of December 31, 2024, the company had 23,601,566 shares of common stock outstanding. Right now, the company has 23,551,859 shares of common stock outstanding. That wraps up my comments; we want to thank you for your interest in and support of SuRo Capital. I'll now hand the call to the operator to begin the Q&A session. Operator?

Brian McKenna

analyst
#6

Looking at today's portfolio, there's clearly plenty to be enthusiastic about, especially with regard to certain investments you've completed lately, plus the pipeline for a number of those IPOs. That said, NAV fell 16% during 2024. So what is the internal base case forecast for NAV growth across 2025? And is there any framework for assessing how much of the legacy portfolio might experience further markdowns going forward?

Mark David Klein

executive
#7

Brian, thank you. I appreciate that. Our practice isn't to provide guidance on a go-forward NAV, since doing so would mean we'd need to know how things get valued at year-end. Still, I believe you could perform certain calculations regardless, if you examine the current marks in our portfolio, consider where the anticipated CoreWeave range sits and where it ends up trading based on how large that investment is, you can definitely form assumptions regarding where it lands. Same situation applies — same with OpenAI, as we did, and we covered that during our opening remarks. Regarding the remaining portfolio, my view is that it's genuinely difficult to say. Clearly, the market volatility seen recently likely makes it even tougher to work that out. Even so, a bit of straightforward arithmetic involving a few of our names would at minimum provide you a sense of where we believe NAV stands right now. As for additional markdowns within the portfolio, our biggest, which we've talked about on this call and talked about with investors, has been Learneo; and we've marked Learneo largely down to, or near, the level where the preference sits within the Learneo capital stack. And that has represented the heaviest drag on our portfolio to the downside. I hope that's helpful.

Marvin Fong

analyst
#8

Your opening comments covered a lot of ground. So I figured I'd just sort of ask about the capital structure; you've put out a similar amount of 6.5% notes to what you bought back in 6% notes, and since you've now bought back your entire authorization of the 6% notes, do you sort of view your appetite for — on the converge structure as pretty much fixed at this point? Or might you think about putting out more notes at the 6.5% to build up your cash on hand and grow your investable assets?

Mark David Klein

executive
#9

Thanks, Marvin. Like you said, we've retired $35 in Allison's remarks, $35 million of our 6% notes maturing at the close of next year. We've put out a like-kind amount of the convertible notes carrying a 6.5% coupon, convertible at $7.75, which represented a 104% premium when issued relative to our stock price back then. And so our debt figure has remained unchanged. Right now, we're at ease with that much — that kind of leverage on our current portfolio. So at this moment I wouldn't expect us to issue any further convertible securities against our current portfolio. We're at ease with our capitalization the way it stands today.

Brian McKenna

analyst
#10

All right, excellent. Mark, I think you said that the current count of pre-IPO businesses in the portfolio is the highest it has ever been, so how much do these investments total in dollars? And then can we think in any way about the percentage of this portion of the portfolio that could reach the public markets within the next year?

Mark David Klein

executive
#11

Excellent question. Well, I'm quite hopeful that CoreWeave reaches the public markets this month. That would be a big one, then. Some of the names that might arrive over the course of the year, I think, include Lime, which has stated very clearly that going public is what they want. Canva could go public by the time the year ends. Liquid Death, I believe, is sometime in the earlier portion of next year. VAST, I think, has been brought up many times as a public company this year, but on that they're rather quiet. So that's broadly — what I mean is, at present, we're able to see — visibility to CoreWeave is clear for us. Everything else, I think, depends somewhat on where the markets stand and how eager people are to really dig into the private markets. But the names we mentioned before are those that fall within sometime from the end of this year to the early part of next year that we believe have a chance to go public.

Mark David Klein

executive
#12

Appreciate everyone being here on this call. Honestly, in spite of how wildly the public markets have been swinging, we see this as a genuinely thrilling moment; the CoreWeave IPO is something we're eager for. So are several of our other portfolio companies, along with all the great things happening inside them. Thanks once more for sticking with us. If anything else comes up or you have any follow-ups, don't hesitate to contact us via the IR portal. Once again, many thanks to all of you.

Operator

operator
#13

Thanks a lot. That brings today's call to a close one more time. You're free to hang up now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete SuRo Capital Corp. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to SuRo Capital Corp. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in SuRo Capital Corp. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.